Literature DB >> 7586675

Spontaneous proliferation of memory (CD45RO+) and naive (CD45RO-) subsets of CD4 cells and CD8 cells in human T lymphotropic virus (HTLV) infection: distinctive patterns for HTLV-I versus HTLV-II.

H E Prince1, J York, S M Owen, R B Lal.   

Abstract

Spontaneous lymphocyte proliferation (SLP) in vitro is a characteristic feature of about 50% of individuals infected with HTLV-I or HTLV-II. Both CD4 cells and CD8 cells contribute to SLP in HTLV-I infection, whereas SLP in HTLV-II infection is usually restricted to CD8 cells. In this study, we asked if SLP was restricted to the memory (CD45RO+) cell subset of CD4 and CD8 cells in HTLV infection. Purified CD4 and CD8 cells were separated into CD45RO+ and CD45RO- populations by a modified panning technique, and spontaneous proliferation (SP) of the cell subsets was assessed. For all five HTLV-I-infected persons whose mononuclear cell cultures were SLP+, only CD45RO+ cells, but not CD45RO- cells, within CD4 and CD8 subsets showed SP. In contrast, five of six SLP+ HTLV-II+ individuals showed SP in both the CD45RO+ and the CD45RO- subsets of CD4 cells, and 10 of 12 SLP+ HTLV-II+ individuals showed SP of both the CD45RO+ and CD45RO- subsets of CD8 cells. Polymerase chain reaction studies showed that proviral genome was generally present in both CD45RO+ and CD45RO- subsets of CD4 and CD8 cells, regardless of HTLV type and SP activity. These findings show that SP of both CD4 and CD8 cells in HTLV-I infection is usually restricted to CD45RO+ memory cells, whereas in HTLV-II infection, both CD45RO+ memory and CD45RO- naive subsets of CD4 and CD8 cells may exhibit SP. It thus appears that HTLV-I infection and HTLV-II infection exhibit distinctive dysregulatory effects on memory and naive T cell subpopulations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7586675      PMCID: PMC1553427          DOI: 10.1111/j.1365-2249.1995.tb03774.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Estimation of rate of incidence of ATL among ATLV (HTLV-I) carriers in Kyushu, Japan.

Authors:  K Tajima; T Kuroishi
Journal:  Jpn J Clin Oncol       Date:  1985-06       Impact factor: 3.019

Review 2.  Infection with HTLV-I and HTLV-II: evolving concepts.

Authors:  J D Rosenblatt; I S Chen; W Wachsman
Journal:  Semin Hematol       Date:  1988-07       Impact factor: 3.851

Review 3.  Manifestations of human T-lymphotropic virus type I infection.

Authors:  J H Kim; D T Durack
Journal:  Am J Med       Date:  1988-05       Impact factor: 4.965

4.  The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I.

Authors:  J E Kaplan; M Osame; H Kubota; A Igata; H Nishitani; Y Maeda; R F Khabbaz; R S Janssen
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

5.  Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy.

Authors:  C L Tendler; S J Greenberg; W A Blattner; A Manns; E Murphy; T Fleisher; B Hanchard; O Morgan; J D Burton; D L Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

6.  Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy.

Authors:  Y Itoyama; S Minato; J Kira; I Goto; H Sato; K Okochi; N Yamamoto
Journal:  Neurology       Date:  1988-08       Impact factor: 9.910

7.  Immunological findings in neurological diseases associated with antibodies to HTLV-I: activated lymphocytes in tropical spastic paraparesis.

Authors:  S Jacobson; V Zaninovic; C Mora; P Rodgers-Johnson; W A Sheremata; C J Gibbs; C Gajdusek; D E McFarlin
Journal:  Ann Neurol       Date:  1988       Impact factor: 10.422

8.  In vivo cellular tropism of human T-cell leukemia virus type 1.

Authors:  J H Richardson; A J Edwards; J K Cruickshank; P Rudge; A G Dalgleish
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

9.  Spontaneous lymphocyte proliferation in human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infection: T-cell subset responses and their relationships to the presence of provirus and viral antigen production.

Authors:  H E Prince; J York; J Golding; S M Owen; R B Lal
Journal:  Clin Diagn Lab Immunol       Date:  1994-05

10.  High human T-cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indian, Guianese, and African patients with tropical spastic paraparesis.

Authors:  A Gessain; F Saal; O Gout; M T Daniel; G Flandrin; G de The; J Peries; F Sigaux
Journal:  Blood       Date:  1990-01-15       Impact factor: 22.113

View more
  3 in total

1.  Peripheral blood mononuclear cells from individuals infected with human T-cell lymphotropic virus type 1 have a reduced capacity to respond to recall antigens.

Authors:  Rita Elizabeth Mascarenhas; Cláudia Brodskyn; Geisa Barbosa; Jorge Clarêncio; Antônio Souza Andrade-Filho; Frederico Figueiroa; Bernardo Galvão-Castro; Fernanda Grassi
Journal:  Clin Vaccine Immunol       Date:  2006-05

2.  [New aspects on the pathogenesis of myositis].

Authors:  B Stuhlmüller; E Feist; T Häupl; G-R Burmester; N Pipitone
Journal:  Z Rheumatol       Date:  2013-04       Impact factor: 1.372

3.  Human T lymphotropic virus type 1 (HTLV-1) proviral load induces activation of T-lymphocytes in asymptomatic carriers.

Authors:  Raimundo Coutinho; Maria Fernanda Rios Grassi; Ana Beatriz Korngold; Viviana Nilla Olavarria; Bernardo Galvão-Castro; Rita Elizabeth Mascarenhas
Journal:  BMC Infect Dis       Date:  2014-08-22       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.